Skip to main content
ImmuneCited

Figure 8

393 × 348px · 9.4 KB

Source Paper

Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways.

Molecules (Basel, Switzerland) (2019)

PMID: 30781885

DOI: 10.3390/molecules24040667

Cite This Figure

![Figure 8: Comparison of resveratrol with conventional endometriosis therapies or other natural compounds, highlighting potential advantages of the polyphenolic approach.](https://pdfs.citedhealth.com/figures/30781885/102.png)

> Source: Ana-Maria Dull et al. "Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and." *Molecules (Basel, Switzerland)*, 2019. PMID: [30781885](https://pubmed.ncbi.nlm.nih.gov/30781885/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/30781885/102.png" alt="Comparison of resveratrol with conventional endometriosis therapies or other natural compounds, highlighting potential advantages of the polyphenolic approach." />
  <figcaption>Figure 8. Comparison of resveratrol with conventional endometriosis therapies or other natural compounds, highlighting potential advantages of the polyphenolic approach.<br>  Source: Ana-Maria Dull et al. "Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and." <em>Molecules (Basel, Switzerland)</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30781885/">30781885</a></figcaption>
</figure>